TITLE

Estrogen did not prevent death or nonfatal stroke in postmenopausal women with ischemic stroke or TIA

AUTHOR(S)
McNagny, Sally E.
PUB. DATE
May 2002
SOURCE
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p96
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Comments on a study which investigated a clinical trial of estrogen-replacement therapy after ischemic stroke. Outcome measures; Effectiveness of estrogen and placebo in preventing death or nonfatal stroke on postmenopausal women with ischemic stroke or transient ischemic attack; Information on hormone replacement therapy.
ACCESSION #
8856097

 

Related Articles

  • How to help women come off HRT. Mansour, Diana // Pulse;3/22/2004, Vol. 64 Issue 12, p60 

    Offers advice on how to help women withdraw from hormone replacement therapy (HRT). Prescription of HRT for menopausal women; Assessment of when women should stop taking HRT; Techniques in HRT withdrawal including the use of oral estrogen-only preparations, cyclical combined therapy and...

  • Postmenopausal hormonal therapy: Current status. V. P., Jyotsna // Indian Journal of Endocrinology & Metabolism;2013 Supplement, Vol. 17 Issue S1, pS45 

    Many trials of the pros and cons of postmenopausal hormone replacement therapy have been done and this treatment has evolved over time. Here, we present a review and current status of this therapy.

  • Oral and transdermal HRT and the risk of stroke.  // Australian Journal of Pharmacy;Dec2010, Vol. 91 Issue 1087, p69 

    The article discusses a study on the association between risk of stroke and the administration of oral and transdermal hormone replacement therapy (HRT) in treating postmenopausal symptoms. It mentions that the trial involved 50-79 years old women in the General Practice Research Database of...

  • A complex question of odds: Hormones vs. no treatment.  // HealthFacts;Jan93, Vol. 18 Issue 164, p1 

    Discusses some of the existing research on the use of postmenopausal hormones. The issue of estrogen usage and risk of breast and uterine cancer and stroke; Reasons for changes in prescribing practices; Criticisms of the existing research; The risk assessment analysis published in the December...

  • The Premarin predicament. Pascoe, Elaine // Practical Horseman;Apr99, Vol. 27 Issue 4, p52 

    Discusses the controversy surrounding Premarin, a brand-name drug extracted from pregnant mares' urine used as a hormone-replacement therapy for menopausal women. Benefits of estrogen; Information on hormone-replacement therapy; Availability of other estrogen products; Information on herbal and...

  • The PMU controversy.  // Practical Horseman;Apr99, Vol. 27 Issue 4, p55 

    Focuses on the growth in the ranching business in North America due to the demand for Premarin, an estrogen product extracted from pregnant mares' urine used as a hormone replacement therapy for menopause. Ranches' adoption of a code of practice for horse care in response to public criticisms...

  • Hormone Replacement Therapy: Optimising the Dose and Route of Administration. Montgomery Rice, V. // Drugs & Aging;2002, Vol. 19 Issue 11, p807 

    Several new products and regimens for estrogen replacement in the postmenopausal woman have recently been introduced, giving physicians and patients greater choice not only in dose but also in route of administration. Estrogen treatment in the postmenopausal woman has several proven benefits for...

  • Use of oestrogen replacement therapy in high risk groups in the United Kingdom. Spector, Tim D. // BMJ: British Medical Journal (International Edition);12/9/89, Vol. 299 Issue 6713, p1434 

    Investigates the use of estrogen replacement therapy in high risk groups in Great Britain. Use of therapy to assess estrogen use among menopausal women; Risks faced by women without ovaries; Factors contributing to the lack of treatment of women at high risks.

  • Decisions in prescribing HRT. Saunders, Carol S. // Patient Care;5/15/2001, Vol. 35 Issue 9, p91 

    Provides information on hormone replacement therapy (HRT) for postmenopausal women. Most commonly prescribed estrogen replacement therapy; Short term indication for HRT; Reasons women discontinue HRT. INSET: HRT counseling requirements from HEDIS.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics